These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19015352)

  • 1. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
    Lamping E; Ranchod A; Nakamura K; Tyndall JD; Niimi K; Holmes AR; Niimi M; Cannon RD
    Antimicrob Agents Chemother; 2009 Feb; 53(2):354-69. PubMed ID: 19015352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei.
    Katiyar SK; Edlind TD
    Med Mycol; 2001 Feb; 39(1):109-16. PubMed ID: 11270397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
    Ricardo E; Miranda IM; Faria-Ramos I; Silva RM; Rodrigues AG; Pina-Vaz C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4604-11. PubMed ID: 24867987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.
    He X; Zhao M; Chen J; Wu R; Zhang J; Cui R; Jiang Y; Chen J; Cao X; Xing Y; Zhang Y; Meng J; Deng Q; Sui T
    PLoS One; 2015; 10(8):e0136185. PubMed ID: 26308936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Azole resistance in Candida spp].
    Kakeya H; Miyazaki T; Miyazaki Y; Kohno S
    Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):87-92. PubMed ID: 12748589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and circulation of azole-resistant
    Ceballos-Garzon A; Peñuela A; Valderrama-Beltrán S; Vargas-Casanova Y; Ariza B; Parra-Giraldo CM
    Front Cell Infect Microbiol; 2023; 13():1136217. PubMed ID: 37026059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
    Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
    PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.
    Monk BC; Niimi K; Lin S; Knight A; Kardos TB; Cannon RD; Parshot R; King A; Lun D; Harding DR
    Antimicrob Agents Chemother; 2005 Jan; 49(1):57-70. PubMed ID: 15616276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei.
    Feng W; Yang J; Wang Y; Chen J; Xi Z; Qiao Z
    Can J Microbiol; 2016 Nov; 62(11):938-943. PubMed ID: 27622981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
    Torelli R; Posteraro B; Ferrari S; La Sorda M; Fadda G; Sanglard D; Sanguinetti M
    Mol Microbiol; 2008 Apr; 68(1):186-201. PubMed ID: 18312269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Set1 Histone H3K4 Methyltransferase Contributes to Azole Susceptibility in a Species-Specific Manner by Differentially Altering the Expression of Drug Efflux Pumps and the Ergosterol Gene Pathway.
    Baker KM; Hoda S; Saha D; Gregor JB; Georgescu L; Serratore ND; Zhang Y; Cheng L; Lanman NA; Briggs SD
    Antimicrob Agents Chemother; 2022 May; 66(5):e0225021. PubMed ID: 35471041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.